Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
22
Number of overlapping holdings
78.6%
% of PBE's 28 holdings also in XBI
16.9%
% of XBI's 131 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PBE |
Weight in XBI |
Overlap | |
---|---|---|---|---|
EXELIXIS INC | 3.1% | 1.1% | 1.1% | |
BIOMARIN PHARMACEUTICAL INC | 5.0% | 1.1% | 1.1% | |
NEUROCRINE BIOSCIENCES INC | 5.3% | 1.1% | 1.1% | |
BLUEPRINT MEDICINES CORP. | 2.8% | 1.1% | 1.1% | |
AMGEN INC | 4.8% | 1.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to XBI
BIO-TECHNE CORPORATION | 4.8% | |
NEUROCRINE BIOSCIENCES INC | 4.3% | |
REGENERON PHARMACEUTICALS | 4.0% | |
GILEAD SCIENCES INC | 3.9% | |
BIOMARIN PHARMACEUTICAL INC | 3.9% | |
VERTEX PHARMACEUTICALS INC | 3.9% | |
AMGEN INC | 3.8% | |
BIOGEN IDEC INC | 3.8% | |
COLLEGIUM PHARMACEUTICAL, INC. | 3.5% | |
INTRA-CELLULAR THERAPIES INC | 2.6% |
PBE Underweight Relative to XBI
EXACT SCIENCES CORP | -1.2% | |
CRINETICS PHARMACEUTICALS INC | -1.2% | |
CYTOKINETICS INC | -1.2% | |
ROIVANT SCIENCES LTD. | -1.2% | |
NATERA INC | -1.2% | |
VIKING THERAPEUTICS, INC. | -1.1% | |
KRYSTAL BIOTECH, INC. | -1.1% | |
ALNYLAM PHARMACEUTICALS INC | -1.1% | |
CEREVEL THERAPEUTICS HOLDINGS INC | -1.1% | |
ARCUTIS BIOTHERAPEUTICS INC | -1.1% |